6-chloro-N-((4,4-difluorocyclohexyl)methyl)-2-(2-methoxyethylamino)quinoline-5-carboxamide

ID: ALA4474419

PubChem CID: 118566610

Max Phase: Preclinical

Molecular Formula: C20H24ClF2N3O2

Molecular Weight: 411.88

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCNc1ccc2c(C(=O)NCC3CCC(F)(F)CC3)c(Cl)ccc2n1

Standard InChI:  InChI=1S/C20H24ClF2N3O2/c1-28-11-10-24-17-5-2-14-16(26-17)4-3-15(21)18(14)19(27)25-12-13-6-8-20(22,23)9-7-13/h2-5,13H,6-12H2,1H3,(H,24,26)(H,25,27)

Standard InChI Key:  FSZBWUFOVGIKHN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
    6.1374  -11.5165    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.7290  -12.2331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5539  -12.2285    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1694  -15.9497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1682  -16.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8830  -17.1899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8812  -15.5369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5966  -15.9461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5974  -16.7729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3127  -17.1839    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0277  -16.7692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0229  -15.9391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3070  -15.5320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4548  -15.5374    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.8787  -14.7119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5919  -14.2973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5895  -13.4724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3028  -13.0577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1630  -14.3016    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0171  -13.4731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7282  -13.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0145  -11.8241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2971  -12.2369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7437  -17.1788    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4566  -16.7636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1727  -17.1733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8855  -16.7580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6016  -17.1677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  4 14  1  0
  7 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 15 19  2  0
 18 20  1  0
 18 23  1  0
 20 21  1  0
 21  2  1  0
  2 22  1  0
 22 23  1  0
 11 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
M  END

Associated Targets(Human)

P2RX7 Tchem P2X purinoceptor 7 (5534 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.88Molecular Weight (Monoisotopic): 411.1525AlogP: 4.50#Rotatable Bonds: 7
Polar Surface Area: 63.25Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.75CX LogP: 3.43CX LogD: 3.43
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.66Np Likeness Score: -1.22

References

1. Xiao Y, Karra S, Goutopoulos A, Morse NT, Zhang S, Dhanabal M, Tian H, Seenisamy J, Jayadevan J, Caldwell R, Potnick J, Bleich M, Chekler E, Sherer B, Sriraman V..  (2019)  Synthesis and SAR development of quinoline analogs as novel P2X7 receptor antagonists.,  29  (13): [PMID:31031055] [10.1016/j.bmcl.2019.04.033]

Source